Navigation Links
World Glaucoma Day Set For March 12, 2009
Date:2/12/2009

ween existing groups, in addition to promoting international awareness of glaucoma as a cause of preventable blindness.

About Robert Ritch, MD, and The New York Eye and Ear Infirmary:

For more than 30 years, Robert Ritch, MD, of The New York Eye and Ear Infirmary, has devoted his career to broadening understanding by the medical profession and patients about the nature of glaucoma and innovation in medical, laser, and surgical treatment of the disease. Dr. Ritch holds the Shelley and Steven Einhorn Distinguished Chair in Ophthalmology and is Surgeon Director and Chief of Glaucoma Services at the New York Eye and Ear Infirmary, New York City and Professor of Clinical Ophthalmology at The New York Medical College, Valhalla, New York.

Founded in 1820, The New York Eye and Ear Infirmary is the first specialty hospital in the Western Hemisphere. It is also one of the largest providers of primary through tertiary eye care in the U.S. with more than 19,000 eye surgeries and 125,000 ophthalmology outpatient visits each year.

Ask yourself on World Glaucoma Day, March 12, 2009

Who is at risk for glaucoma?

Anyone can develop glaucoma. Some people are at higher risk than others. They include:

  • African-Americans over age 40.
  • Everyone over age 60
  • People with a family history of glaucoma
  • People who are very nearsighted or farsighted

Among African-Americans, studies show that glaucoma is:

  • Five times more likely to occur in African-Americans than in Caucasians
  • About four times more likely to cause blindness
  • Fifteen times more likely to cause blindness in African-Americans between the ages of 45-64 than in Caucasians of the same age group

'/>"/>
SOURCE The New York Eye & Ear Infirmary
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Medical Tourism Comes to Macao -- Worlds Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel
2. Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel
3. Sensiotec Announces FDA 510(k) Class II Clearance for the Worlds First UWB Healthcare Unbound, Wireless, Non-Contact, Vital Signs and Movement Monitor
4. Worlds First Cardiac Adult Stem Cell Trial to Take Place in Louisville
5. HTH Worldwide to Provide Mobile Healthcare Tool to UNIGLOBE Travel Internationals Agencies
6. Healthcare Online Regulations to Be Discussed in Live Event and Webcast Hosted by Waggener Edstrom Worldwide
7. Healthcare Online Regulations Discussed in Live Event and Webcast Hosted by Waggener Edstrom Worldwide
8. WorldHeart Appoints New President and CEO
9. World Cancer Day Highlights Link Between Overweight and Cancer
10. "Viral Campaign May Lead to Guinness World Record"
11. How much is the world spending on neglected disease research and development?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... The genome we inherited from our parents shapes many ... genome we have an epigenome that is set during ... and environmental exposuresand perhaps by those of our parents ... on our DNA and supporting proteins that determine whether ... are deeply responsible for our own health, but also ...
(Date:8/27/2014)... growth in health care spending for commercially insured individuals ... services, rather than increased use, according to a new ... Health Policy & Clinical Practice, published in the August ... . , There is increasing concern that consolidation in ... faced by payers and, ultimately, consumers," said Carrie Colla, ...
(Date:8/27/2014)... NJ (PRWEB) August 27, 2014 ... leading pediatric practice, Hoboken Pediatrics has joined our ... Dr. Andrzej Klos, Dr. Piotr Oko, Dr. Yanina ... Hundreds of highly skilled and experienced physicians comprise ... top doctors and practices in Hudson County, representing ...
(Date:8/27/2014)... Scientists at The Scripps Research Institute (TSRI) have ... can be associated with alcohol dependence. , This ... type 1 (Nf1), which TSRI scientists found is linked ... Nf1 regulates gamma-aminobutyric acid (GABA), a neurotransmitter that lowers ... novel and seminal study provides insights into the cellular ...
(Date:8/27/2014)... Silver Spring and Germantown, Md., and Denver (PRWEB) August ... healthcare real estate developer , has broken ground ... on the new Holy Cross Health hospital campus in ... of Bethesda, Md. Germantown is the third most populous ... medical office building on the Holy Cross Germantown Hospital ...
Breaking Medicine News(10 mins):Health News:Scientists map the 'editing marks' on fly, worm, human genomes 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 3Health News:Scientists map the 'editing marks' on fly, worm, human genomes 4Health News:Tracking spending among the commercially insured 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 3Health News:Scripps Research Institute scientists link alcohol-dependence gene to neurotransmitter 2Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 2Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 4
... Since mephedrone was made illegal in the UK in 2010, the ... degraded, which in turn may have reduced use of the drug. ... continued to use mephedrone after it became illegal would switch to ... by their friends or on the Internet. They would be ...
... health records (EHRs) are rapidly becoming part of the ... of care. In the first large study of its ... Nursing determined that nurses working with EHRs consistently reported ... for patients than nurses working in hospitals without this ...
... , TUESDAY, Jan. 17 (HealthDay News) -- With the Alzheimer,s ... ages, a panel of experts is meeting for two days ... fast emerging as one of the nation,s biggest -- and ... is to improve diagnosis, buttress support and training programs for ...
... drug called regorafenib slowed the progression of tumors and lengthened ... an international phase III clinical trial found. The findings were ... American Society of Clinical Oncology in San Francisco by ... principal investigator of the trial in the United States. ...
... are performed on all newborns born in the U.S. ... are not apparent at birth. These newborn screening programs ... early and improve outcomes in potentially devastating conditions. ... the data collection linked to newborn screening results, aiming ...
... Jan. 16, 2012 Listen up, pedestrians wearing headphones. ... Many probably can,t, especially young adult males. Serious ... in six years, according to new research from the University ... Medical Center in Baltimore. In many cases, the cars ...
Cached Medicine News:Health News:Despite the risks, mephedrone users in the UK are ready to try the next legal high 2Health News:Better together - The RN and the EHR 2Health News:U.S. Wants to Buttress Alzheimer's Arsenal by 2025 2Health News:U.S. Wants to Buttress Alzheimer's Arsenal by 2025 3Health News:Drug improves survival of colorectal cancer patients, trial results show 2Health News:Newborn screening program aims to help transform treatments for genetic diseases detected at birth 2Health News:Newborn screening program aims to help transform treatments for genetic diseases detected at birth 3Health News:University of Maryland study: Headphone-distracted pedestrians face death, serious injury 2Health News:University of Maryland study: Headphone-distracted pedestrians face death, serious injury 3
(Date:8/27/2014)... Aug. 27, 2014  Columbia Laboratories, Inc. (Nasdaq: ... of pharmaceutical development, clinical trial manufacturing, and advanced analytical ... that it will participate at the upcoming Rodman & ... be held in New York . ... on September 9, 2014 at the New York Palace ...
(Date:8/27/2014)... and NINGBO, China , Aug. ... Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") today announced they ... of generic pharmaceuticals, primarily targeting the United ... agreement, Amerigen and Menovo will jointly develop products for ... . Menovo will be responsible for manufacturing API ...
(Date:8/27/2014)... Aug. 27, 2014 /CNW/ - Covalon Technologies Ltd. (the "Company" ... the following financial results for its third quarter of fiscal ... 2014: , Revenue of $1,291,378, a 13% decrease ... Net loss for the quarter of $240,156 compared to net ... year For the nine months ended June ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... from Biodel Inc. (Nasdaq: BIOD ) reported ... basal insulin and stabilized glucagon development programs in poster ... Technology Meeting in Bethesda, MD.   Dr. ... double-blind, randomized crossover trial in 13 subjects with type ...
... (NYSE Amex: NBS ) ("NeoStem" or the ... revenues, global research and development capabilities and operations in ... adult stem cells, and China pharmaceuticals, is today providing ... Third Quarter Results Revenues for the nine ...
Cached Medicine Technology:Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 2Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 3Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 4Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 5NeoStem Provides Third Quarter Update 2NeoStem Provides Third Quarter Update 3
The Onar®Lp test system is an in vitro test for the qualitative diagnosis of legionella in clinical samples....
The Onar®Lp -QP test system is an in vitro test for the quantitative diagnosis of legionella in clinical samples....
Designed for OSA patients who have difficulty with conventional CPAP therapy, the ResMed SULLIVAN Comfort system is a solution for those who need an alternative to CPAP....
... an approach to treatment that ... pressure range to 25 cm ... treat patients with severe OSA. ... integrated humidification and built-in Encore® ...
Medicine Products: